International Journal of Gynecological Cancer

Papers
(The H4-Index of International Journal of Gynecological Cancer is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-10-01 to 2025-10-01.)
ArticleCitations
Role of pre-diagnostic reproductive factors on long-term (10 years or greater) survival of epithelial ovarian cancer: The Extreme study282
Computed tomography–based prediction of interval cytoreduction in advanced ovarian cancer164
Patterns of care and development of quality indicators in patients with non-epithelial and rare ovarian tumors in Australia: insights from the National Gynae-Oncology Registry134
Primary ovarian leiomyosarcoma: results from an analysis by the French Sarcoma Group (Ovarian SArcoma MAnagement – OSAMA Study)124
Three-dimensional image of uterine transposition102
Pelvic lymph node decidua mimicking metastatic cervical cancer in pregnancy95
Growing teratoma syndrome70
Inguinofemoral lymphadenectomy technique in 10 steps65
The Asia-Pacific Gynecologic Oncology Trials Group (APGOT): building a Pan-Asian and Oceania women’s cancer research organization63
The Cukurova score in the prediction of primary cytoreduction in ovarian cancer59
Survey on implementation of molecular testing in ovarian cancer and PARP inhibitor: a national North-Eastern German Society of Gynecologic Oncology/Young Academy of Gynecologic Oncology/Arbeitsgemeins53
A population-based study of outcomes in adjuvant radiotherapy for stage II endometrial carcinoma53
Surgical technique and surgeon volume: the pursuit of data-driven outcomes51
Surgical staging for locally-advanced cervical cancer: the answer remains ‘NO’45
Successful cervical cancer treatment during a monochorionic diamniotic twin pregnancy in a patient with history of preterm delivery44
Correction: SUCCOR quality: validation of ESGO quality indicators for surgical treatment of cervical cancer43
Management of stage III and IVa uterine cancer42
Management of intravenous leiomyomatosis: a comprehensive review of surgical and perioperative considerations41
Well-differentiated papillary mesothelial tumor of the peritoneum41
Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico41
Complementary use of indocyanine green and technetium to enhance sentinel lymphadenectomy in vulvar cancer41
Dual mechanical and pharmacological thromboprophylaxis decreases risk of pulmonary embolus after laparotomy for gynecologic malignancies40
A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets39
Transfusion use and effect on progression-free, overall survival, and quality of life in upfront treatment of advanced epithelial ovarian cancer: evaluation of the European Organization for Research a38
Improvement in radiation techniques for locally advanced cervical cancer during the last two decades38
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 202438
Safety and management of niraparib monotherapy in ovarian cancer clinical trials37
Authors’ response to: “Methodological concerns regarding AGO score validation in low-grade ovarian cancers”36
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma34
Epithelial ovarian cancer and borderline tumors during pregnancy: a report from the International Network on Cancer, Infertility, and Pregnancy34
22nd meeting of the European Society of Gynaecological Oncology (ESGO 2021) report34
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer33
Survival impact of histological response to neoadjuvant chemotherapy according to number of cycles in patients with advanced ovarian cancer32
Vaginal cuff brachytherapy for endometrial cancer: a review of major clinical trials with a focus on fractionation32
2.491555929184